ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
Condition: X-linked Retinoschisis · Sponsor: Atsena Therapeutics Inc.
About this study
This study will evaluate the safety and efficacy of ATSN-201 in subjects ≥ 6 years of age with RS1-associated X-linked retinoschisis (XLRS).
This description comes directly from the study's public registry record.
Talk to the study team
Atsena Therapeutics Clinical Trials · 984-261-2001 · clinicaltrials@atsenatx.com
Always discuss trial participation with your own doctor first.
Locations (19)
| Associated Retina Consultants | Phoenix, Arizona, United States | Recruiting |
| Shiley Eye Institute | La Jolla, California, United States | Not Yet Recruiting |
| Children's Hospital of Los Angeles | Los Angeles, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Not Yet Recruiting |
| UC San Francisco | San Francisco, California, United States | Not Yet Recruiting |
| Bascom Palmer Eye Institute | Miami, Florida, United States | Recruiting |
| Massachusetts Eye and Ear | Boston, Massachusetts, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Columbia University | New York, New York, United States | Not Yet Recruiting |
| Flaum Eye Institute, University of Rochester | Rochester, New York, United States | Not Yet Recruiting |
+ 7 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05878860